Notice of General Meeting
Notice of General Meeting 2023 (final)
Motor Neurone Disease Clinical Trial Update
Motor Neurone Disease Clinical Trial Update (final)
Progress update on Phase 1/2 MND interim analysis
Progress update on Phase 12 MND interim analysis (final)
Independent tests show MPL retains long-term shelf-life
12-month GMP Stability (final)
MPL has anti-cancer effects across multiple cancer types
MPL has anti-cancer effects across multiple cancer types (final)
PharmAust Raises $2.5m via Placement
PharmAust Raises $2.5m via Placement
Top 20 Shareholders April 2023
Top_Holders_Report (23)
MND Trial Successfully Completes Second Patient Cohort
MND Trial Successfully Completes Second Patient Cohort (final)(RA)
Appendix 4C and Quarterly Update
Appendix 4C and Quarterly Update – March 2023
Canine Trial Update
PAA Canine Trial Update – April 2023 (final)